Headlines
-
AdPha’s MM2025 kicks off
Friday | Nov 28 2025ADVANCED Pharmacy Australia (AdPha) launched Medicines Management 2025 - Australia's largest scientific pharmacy conference - this morning, with President Associate Professor Tom Simpson providing delegates with an overview of organisation's achievements over the last year, and the future direction for AdPha and hospital pharmacy.
-
PSA launches new aged care summit
Friday | Nov 28 2025THE Pharmaceutical Society of Australia (PSA) will hold its inaugural Aged Care Pharmacist Summit next year, bringing together Australia's leaders in aged care to champion the role of pharmacists in protecting older Australians from medicine-related harm and maximising quality of life.
-
Call for T1D screening
Thursday | Nov 27 2025MEDICAL experts and advocates are calling for nationwide screening for type 1 diabetes (T1D), with new screening methods capable of identifying the condition years before symptoms appear.
-
New asthma guide can save lives
Thursday | Nov 27 2025AUSTRALIAN Bureau of Statistics (ABS) data released by the National Asthma Council Australia (NAC) has revealed that 478 people lost their lives in 2024 due to asthma.
-
Distributive justice failing
Thursday | Nov 27 2025A NEW study has found that medicines tested internationally for approval by the US Food and Drug Administration (FDA) are not available in many of the countries where the testing was conducted, raising ethical concerns about exploitation and who benefits from drug testing.
-
A year of growth and delivery
Wednesday | Nov 26 2025THE Pharmaceutical Society of Australia (PSA) has released its 2024/25 Annual Report, chronicling a year characterised by strong growth and delivery in terms of membership numbers, member support, training and education products and services, policy submissions, partnerships and general investment income.
-
TGA acts to restrict B6 with new S3 category
Wednesday | Nov 26 2025THE Therapeutic Goods Administration (TGA) has announced its decision to strengthen safety controls for products containing vitamin B6, with the aim of reducing the risk of nerve damage associated with the long-term consumption of high doses (PD 05 Jun).
-
Gongs for leaders in pharmacy education
Tuesday | Nov 25 2025THE Australian Pharmacy Council (APC) has announced the four recipients of the 2025 APC Dr Erica Sainsbury awards, which were presented at the Emeritus Lloyd Sansom AO Distinguished Lecture Series in Canberra last night.
-
HPV vax and screening decline
Tuesday | Nov 25 2025FALLING HPV vaccination and cervical screening rates are putting elimination of cervical cancer in Australia at risk, according to the latest annual report by the NHMRC Centre of Research Excellence in Cervical Cancer Control.
-
T2D drug helps with type 1 diabetes
Tuesday | Nov 25 2025RESEARCHERS at the Garvan Institute have discovered that metformin, a drug typically used in type 2 diabetes, reduces insulin needs in type 1 diabetes, opening the door for improved management of the condition.
